$8.03 Billion is the total value of HHLR ADVISORS, LTD.'s 54 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALGN | Buy | ALIGN TECHNOLOGY INC | $656,746,000 | +131.9% | 2,353,591 | +50.3% | 8.18% | +110.1% |
| ZM | New | ZOOM VIDEO COMMUNICATIONS INcl a | $470,570,000 | – | 6,916,078 | +100.0% | 5.86% | – |
| UBER | Buy | UBER TECHNOLOGIES INC | $461,018,000 | +22.7% | 15,501,624 | +25.8% | 5.74% | +11.3% |
| FGEN | Buy | FIBROGEN INC | $169,664,000 | +31.0% | 3,955,787 | +12.9% | 2.11% | +18.7% |
| VIE | New | VIELA BIO INC | $124,650,000 | – | 4,591,176 | +100.0% | 1.55% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $120,533,000 | +9.5% | 1,504,599 | +0.4% | 1.50% | -0.8% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $20,969,000 | +31.9% | 1,895,888 | +1.5% | 0.26% | +19.7% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $19,780,000 | +16.0% | 891,201 | +18.9% | 0.25% | +5.1% |
| QCOM | New | QUALCOMM INC | $17,646,000 | – | 200,000 | +100.0% | 0.22% | – |
| MRUS | New | MERUS N V | $8,448,000 | – | 600,000 | +100.0% | 0.10% | – |
| ARGX | New | ARGENX SEsponsored adr | $8,026,000 | – | 50,000 | +100.0% | 0.10% | – |
| AMG | New | AFFILIATED MANAGERS GROUP IN | $6,046,000 | – | 71,345 | +100.0% | 0.08% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.